Analysis of iASPP mutations in a wide range of cancers did not reveal particular hotspot mutations and, unlike the mutations associated with cardiomyopathy, most of the mutants selected for further characterisation neither aggregated nor reside at the hydrophobic core or binding interface between iASPP and p53. This evidence concerns the gene PPP1R13L and cardiomyopathy.